UnitedHealth lifts 2026 EPS view on Medicare strength, commercial lags
UnitedHealth Group raised its 2026 earnings forecast after a sharp increase in second-quarter profit driven by Medicare Advantage, though elevated commercial medical costs continue to delay a full margin recovery.
UnitedHealth Group posted adjusted earnings per share of $6.38 for the second quarter, up sharply from $4.08 a year earlier and surpassing market expectations. Operating earnings surged 55% year over year to $8 billion, while total revenue reached $112 billion. Chief Financial Officer Wayne DeVeydt noted the top line was "largely consistent" with the prior year.
Buoyed by the robust quarterly performance, the healthcare conglomerate raised its full-year 2026 adjusted EPS guidance to a range of $19.50 to $20. Chief Executive Officer Stephen Hemsley attributed the improvement to "continuing progress toward delivering more consistent and dependable performance," pointing to targeted gains derived from Medicare benefit planning and design.
The primary engine for the quarter was the firm's Medicare Advantage business, which successfully leveraged recent portfolio adjustments to boost profitability. Furthermore, all three segments of UnitedHealth's Optum health services unit tracked in line or ahead of internal plans, reinforcing the division's role as a critical earnings stabilizer. DeVeydt credited the turnaround to "product and portfolio actions taken over the past 12 months, along with more focused and consistent management disciplines."
Despite the upward revision to overall guidance, the company's commercial insurance segment remains a notable headwind for investors to watch. Management cautioned that medical cost trends in this division are still running higher than anticipated. While the company still targets commercial group margins of 7% or better, executives now characterize the rebound as a multi-year effort that will not materialize until well beyond 2027. Hemsley emphasized that the insurer is remaining "respectful of persistently elevated medical costs" in the current environment.
To reward shareholders amid the mixed operational backdrop, UnitedHealth expanded its capital return programs. The company increased share repurchases to at least $5 billion for 2026 and raised its dividend. Management also highlighted broader AI adoption and prior authorization reductions as structural levers designed to drive long-term efficiency and offset future cost pressures.
